Moderna vs ParcelBio
Moderna vs ParcelBio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moderna is on 77/100 and ParcelBio on 52/100.
Where each one leads
Moderna
- our overall score: 77/100 against 52/100
- agent readiness: 49/100 against 33/100
- domain rating: 79/100 against 17/100
- headcount: 6,297 against 6
- funding raised: $4.5B against $100M
- LinkedIn following: 780,086 against 1,243
ParcelBio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Moderna | ParcelBio |
|---|---|---|
| What it is | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. | Advancing next-generation mRNA medicines. |
| Category | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals | Biotechnology, Pharmaceuticals, HealthTech, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2010 | 2023 |
| Headquarters | Cambridge, United States | San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Moderna | ParcelBio |
|---|---|---|
| Employees | 6,297 | 6 |
| Open roles | 100 | Not published |
| Total funding | $4.5B | $100M |
| Latest round | Funding Round | Series A |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 780,086 | 1,243 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moderna | ParcelBio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 77/100 | 52/100 |
| Traction | 60/100 | 48/100 |
| Team | 70/100 | Not published |
| Community | 13/100 | Not published |
| Search visibility | 46/100 | 33/100 |
| Quality | 90/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (33/100) |
| Domain ratingLink authority, 0-100 | 79/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moderna | ParcelBio |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | CloudFront | Cloudflare |
| CMS | Not detected | Webflow |
| Frameworks | Next.js | Not detected |
What users say
| Measure | Moderna | ParcelBio |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 2.0/5 from 1 vote | Not published |
Moderna vs ParcelBio: common questions
Which is better, Moderna or ParcelBio?
On our 0-100 score Moderna rates higher (77/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Moderna and ParcelBio compare on the numbers?
Moderna leads on our overall score (77/100 against 52/100), agent readiness (49/100 against 33/100), domain rating (79/100 against 17/100), headcount (6,297 against 6), funding raised ($4.5B against $100M), LinkedIn following (780,086 against 1,243).
Read the full Moderna review and pricing or the ParcelBio review and pricing. You can also browse other Moderna alternatives we track.